Related Sciences

Related Sciences (RS) is a data science-driven drug discovery firm. RS invests in and leads the discovery of valuable preclinical medicines utilizing a specialized new model designed from the ground up to improve capital efficiency, operational scalability, and deliver superior risk-adjusted returns. RS uses a proprietary AI/ML platform to identify the best new opportunities for every disease, assembles large decentralized teams of field-leading researchers to guide world-class science, and then leads efficient, multi-modality drug discovery via preclinical-specialized staff and R&D platforms. The RS mission is to deliver a new biotech investment paradigm with a significantly improved risk-reward profile to accelerate the creation of transformative new medicines for patients, and to materially broaden the sector’s investor appeal. RS was founded by a multi-disciplinary team of drug discovery, data science, and private equity veterans who have built and led biotech companies worth billions and is backed by a luminary group of investors.